Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 52-Week High

Teva Pharmaceutical Industries' stock reached a new 52-week high, trading as high as $30.30. Several analysts have issued reports on TEVA shares, with an average rating of "Buy" and a consensus price target of $30.25. A director, Roberto Mignone, sold 200,000 shares at an average price of $24.11.